Insulet Corporation (PODD)
NASDAQ · Healthcare · Medical Devices
Insulet Corporation is a Healthcare company with a market capitalization of $10.65B and a trailing P/E ratio of 35.9.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $1.30 | $1.16 | +12.1% |
| Q4 2025 | February 18, 2026 | $1.55 | $1.46 | +6.2% |
| Q3 2025 | November 6, 2025 | $1.24 | $1.15 | +7.8% |
| Q2 2025 | August 7, 2025 | $1.17 | $0.92 | +27.2% |
| Q1 2025 | May 8, 2025 | $1.02 | $0.79 | +29.1% |
| Q4 2024 | February 20, 2025 | $1.15 | $1.02 | +12.6% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Insulet Corporation's market cap?
As of June 29, 2026, Insulet Corporation (PODD) has a market capitalization of $10.65B.
What is Insulet Corporation's P/E ratio?
Insulet Corporation trades at a trailing price-to-earnings (P/E) ratio of 35.9. Its forward P/E is 24.8.
Does Insulet Corporation pay a dividend?
Insulet Corporation does not currently pay a dividend.
What sector is PODD in?
Insulet Corporation is in the Healthcare sector, specifically the Medical Devices industry.
What was Insulet Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Insulet Corporation reported revenue of $2.71B and net income of $247.10M.
Ask your own questions about PODD
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.